Hygea vct provides investors with access to a diversified portfolio of emerging and established MedTech companies qualifying for investment by a VCT. The board has a strong track record of investing in this area and has a network of personnel with successful P&L responsibility experience in the MedTech sector, both in the UK and
internationally.
A key feature of the Hygea investment approach is to ensure that portfolio companies are developed as solutions companies i.e. compete on the basis of value provided to customers (not price) by providing better patient outcomes at lower total cost. The effect of this approach is that portfolio companies tend to be focused around medical devices, drug delivery systems, diagnostics and technology based support services - standalone molecule development companies do not generally qualify as solutions companies.
Website:www.hygeavct.com
Industries:
Biotechnology
Health Care
Pharmaceutical
Commercial
Robotics
Analytics
Database
3D Technology
Medical Device
Video Games
Health Diagnostics
Manufacturing
3D Printing
Hardware
Software
Environmental Engineering
Natural Resources
Biopharma
Education
Medical
Investor Types:
Venture Capital
Investment Stages:
Late Stage Venture
Location:
Highland, United Kingdom
Contact information:
